title: Is olanzapine a brain-sparing medication?
authors.forename: Ridha
authors.initials: R
authors.lastname: Joober
authors.forename: Norbert
authors.initials: N
authors.lastname: Schmitz
authors.forename: Ashok
authors.initials: A
authors.lastname: Malla
authors.forename: Sarojini
authors.initials: S
authors.lastname: Sengupta
authors.forename: Sherif
authors.initials: S
authors.lastname: Karma
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects / Q000502:physiology; D000077152:Olanzapine; D012107:Research Design / Q000592:standards; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015430:Weight Gain / Q000187:drug effects / Q000502:physiology
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine